K254004 is an FDA 510(k) clearance for the VRNT. Classified as Virtual Reality Behavioral Therapy Device For Pain Relief (product code QRA), Class II - Special Controls.
Submitted by Cognifisense, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on April 10, 2026 after a review of 116 days - within the typical 510(k) review window.
This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5800 - the FDA physical medicine device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.